CN110123981A - A kind of Chinese medicine aromatotherapy composition and its application for having effects that intelligence promoting and tranquilization and helping sleep - Google Patents
A kind of Chinese medicine aromatotherapy composition and its application for having effects that intelligence promoting and tranquilization and helping sleep Download PDFInfo
- Publication number
- CN110123981A CN110123981A CN201910446153.1A CN201910446153A CN110123981A CN 110123981 A CN110123981 A CN 110123981A CN 201910446153 A CN201910446153 A CN 201910446153A CN 110123981 A CN110123981 A CN 110123981A
- Authority
- CN
- China
- Prior art keywords
- flower
- drug
- composition
- sleep
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 69
- 230000007958 sleep Effects 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 230000000694 effects Effects 0.000 title claims abstract description 29
- 230000001737 promoting effect Effects 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 26
- 241000628997 Flos Species 0.000 claims abstract description 20
- 239000000126 substance Substances 0.000 claims abstract description 19
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 16
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 16
- 241000196324 Embryophyta Species 0.000 claims abstract description 14
- 239000002023 wood Substances 0.000 claims abstract description 12
- 241001373816 Saussurea laniceps Species 0.000 claims abstract description 9
- 241001127714 Amomum Species 0.000 claims abstract description 8
- 241000271309 Aquilaria crassna Species 0.000 claims abstract description 8
- 241001113925 Buddleja Species 0.000 claims abstract description 8
- 241001164374 Calyx Species 0.000 claims abstract description 8
- 240000001548 Camellia japonica Species 0.000 claims abstract description 8
- 241001546929 Campsis grandiflora Species 0.000 claims abstract description 8
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 8
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 8
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 8
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 8
- 244000018795 Prunus mume Species 0.000 claims abstract description 8
- 235000011158 Prunus mume Nutrition 0.000 claims abstract description 8
- 241000220317 Rosa Species 0.000 claims abstract description 8
- 235000000340 Solanum pseudocapsicum Nutrition 0.000 claims abstract description 8
- 235000010749 Vicia faba Nutrition 0.000 claims abstract description 8
- 240000006677 Vicia faba Species 0.000 claims abstract description 8
- 235000002098 Vicia faba var. major Nutrition 0.000 claims abstract description 8
- 240000004482 Withania somnifera Species 0.000 claims abstract description 8
- 235000001978 Withania somnifera Nutrition 0.000 claims abstract description 8
- 235000018597 common camellia Nutrition 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 235000008384 feverfew Nutrition 0.000 claims abstract description 8
- 239000004615 ingredient Substances 0.000 claims abstract description 8
- 244000138993 panchioli Species 0.000 claims abstract description 8
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims abstract description 7
- 239000003960 organic solvent Substances 0.000 claims description 17
- 239000000284 extract Substances 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000000638 solvent extraction Methods 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 229940100688 oral solution Drugs 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- 239000002304 perfume Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 3
- 230000018044 dehydration Effects 0.000 claims description 3
- 238000006297 dehydration reaction Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000001256 steam distillation Methods 0.000 claims description 3
- 238000007803 cold maceration Methods 0.000 claims description 2
- 229910052738 indium Inorganic materials 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000004575 stone Substances 0.000 claims 1
- 210000001835 viscera Anatomy 0.000 abstract description 15
- 230000008901 benefit Effects 0.000 abstract description 11
- 244000223014 Syzygium aromaticum Species 0.000 abstract description 7
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract description 7
- 241000411851 herbal medicine Species 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 230000010415 tropism Effects 0.000 abstract description 5
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 230000008092 positive effect Effects 0.000 abstract description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 20
- 206010022437 insomnia Diseases 0.000 description 20
- 230000004069 differentiation Effects 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 15
- 230000036578 sleeping time Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 241000256856 Vespidae Species 0.000 description 10
- 206010003084 Areflexia Diseases 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 230000028527 righting reflex Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 8
- 229960000796 barbital sodium Drugs 0.000 description 7
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 7
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 7
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000000571 coke Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 244000144993 groups of animals Species 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 230000004620 sleep latency Effects 0.000 description 6
- 240000002853 Nelumbo nucifera Species 0.000 description 5
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 5
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 230000000147 hypnotic effect Effects 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 210000000885 nephron Anatomy 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 208000035755 Psychosomatic disease Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 238000002664 inhalation therapy Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007928 intraperitoneal injection Substances 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000002475 olfactory pathway Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000010341 ping gan Substances 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 208000022925 sleep disturbance Diseases 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000143437 Aciculosporium take Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241001145025 Saussurea involucrata Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 229960005143 amobarbital sodium Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 230000007119 pathological manifestation Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- BNHGKKNINBGEQL-UHFFFAOYSA-M sodium;5-ethyl-5-(3-methylbutyl)pyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CC(C)CCC1(CC)C(=O)NC(=O)[N-]C1=O BNHGKKNINBGEQL-UHFFFAOYSA-M 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine aromatotherapy composition for having effects that intelligence promoting and tranquilization and helping sleep, the composition is made of the bulk pharmaceutical chemicals of such as the following parts by weight: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, Flos Hibisci Mutabilis, camellia, west safflower, finger citron flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower, cortex cinnamomi, Saussurea laniceps flower, cloves, agalloch eaglewood, villous amomum flower.The invention also includes combination of the above objects to prepare the application in the drug that intelligence promoting and tranquilization helps sleep.The treatment method of the drug includes: fragrant inhalation and fragrant Transdermal absorption method, and advantage is shown: 1, with pure natural aromatics flowers and aromatics plant composition of prescription, not containing any artificial synthetic ingredient;2, under the guidance of diagnosis and treatment based on an overall analysis of the illness and the patient's condition principle, selected each herbal medicine all passes through four natures and five flavors of drug, ascending-aescending-floating-sinking, and channel tropism enters internal organs and modern pharmacology research, there was only excellent positive effect to human body, and without any side effects.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, specifically, being a kind of Chinese medicine virtue for having effects that intelligence promoting and tranquilization and helping sleep
Fragrant therapy composition and its application.
Background technique
The time that there is one third in all one's life of people is spent in sleep, and in sleep procedure, whole body includes maincenter mind
It is all restored and rests through system.Neuron and linked groups' restoration and reconstruction and regeneration need the rest of body, and only sleep
Dormancy state can provide this rest.Sleep has many functions, including restores attention, promotes growth and consolidating memory gentle
Solve intense strain etc..Sleep is the important link of body recovery, integration and consolidating memory, and sleep is that health is indispensable important
Component part is that healthy life institute is required.
Insomnia is the most common sleep disturbance, is one of most common psychosomatic disease symptom, caused by referring to a variety of causes
Sleep insufficiency, difficulty falling asleep, early awakening, patient often have mental fatigue, feel dizzy, tinnitus of having a headache, shortness of breath and palpitation, memory do not collect
In, the performance such as work efficiency drop.
Patient generally enters the prolongation of latency of sleep, and sleeping time shortens, and physiology sexual arousal increases in process of falling asleep.
Main performance: less serious case's difficulty falling asleep, Yi Xing in sleep, and be difficult to fall asleep again;Early morning wakes up too early.Severe one is lain awake all night, often
With headache and dizzy, spiritlessness and weakness, palpitation and amnesia, confused and worried, dreaminess etc., patient often experiences anxiety to insomnia and fear.
Primary insomnia generates insomnia since nervous, anxiety is frightened.Insomnia secondary, secondary to body
Factor, environmental factor, neuropsychiatric disease etc..
The harm of insomnia: (1) insomnia causes body immunity to decline, and weakens to the resistance of various diseases.(2) insomnia is drawn
Play failure of memory, headache.(3) insomnia influences work, studying and living.(4) insomnia can lead to vegetative nervous disorder.(5) it passes through
Often insomnia can cause senile dementia.(6) often insomnia made one presenility, shortened the service life.(7) children sleeping deficiency will affect
The growth and development of body.
At present from Chinese medicine angle, dialectical main sick position of having a sleepless night is had ants in one's pants and is lost due to mind dystrophy or uneasiness in the heart
It sleeps, but related to the yin and yang qi and blood disorder of liver, gallbladder, spleen, stomach, kidney.Specifically have 7 card types: (1) internal heat is partially high;(2) liver depression
Fire;(3) it is disturbed in phlegm heat;(4) stomach Qi is become estranged;(5) fire excess from yin deficiency;(6) insufficiency of heart and spleen;(7) the heart and gallbladder deficiency of vital energy.
Western medical treatment: the treatment having a sleepless night at present on the basis of active treatment primary disease, while taking some adjusting nerves
The treatment insomnia of the methods of drug of system;Chinese traditional treatment: Chinese herbal medicine decoction of medicinal ingredients takes orally and acupuncture and moxibustion therapy.
Aromatotherapy is that dosage form appropriate is made with the plant of fragrant odour to act on whole body or part, with prevent and treat physiology with
Mental disease, a kind of sanatory medical health method.
It is closely bound up that fragrant plant performance drug effect also functions approach.Current most widely used, most study method
It is fragrant inhalation therapy and fragrant Transdermal absorption therapy.
Fragrant Transdermal absorption refers to that so that aromatic substance is passed through skin in a short period of time by massage method enters blood
It recycles (cell tissues such as nerve, bone, muscle can be affected by it), so as to achieve the aim of preventing and treating diseases
Fragrant inhalation therapy, which then refers to, directly acts on central nervous system by olfactory pathway, while passing through lung, leads to
Gas exchanges are crossed, into blood circulation, play the role for the treatment of disease.
As a branch of herbology, aromatotherapy is because the therapeutic effect of its natural quality and natural green is by increasingly
More people are received.This method have the characteristics that letter, just, it is honest and clean, test, it is sufficient to make up the deficiency of decoction of medicinal ingredients for oral administration, can widely apply
In clinical departments.
Aromatotherapy treatment insomnia has the advantage that
1. avoiding Chinese and western drugs takes side reaction orally, it is easy to be received by psychosomatic disease patient.
2. avoid the nociception of acupuncture and moxibustion therapy with it is invasive, be easy to be received by psychosomatic disease patient.
3. especially fragrant inhalation is treated due to directly acting on nervous centralis by olfactory pathway in nervous system disease
In have unique advantage.
4. the effect of the therapeutic effect of its natural quality and natural green " controlling " existing to disease plays the role of " preventing ", easily again
In by receiving popularization and application.
It although aromatotherapy is originating from Europe, is grown up on the basis of traditional medical theory between east and west, application
It is more affected by the influence of west tradition herbology, but the herbal medicine theory in west is limited only to effect and usage, therewith
There is more deep Clinical significance of MG to aromatotherapy compared to the traditional Chinese medicine theories of Chinese materia medica in China.
Inventor has studied Chinese medicine aromatotherapy composition and its application that a kind of intelligence promoting and tranquilization of the present invention helps sleep, this hair
It is bright to use Chinese medicine aromatotherapy, the acceptance of patient is improved, yet there are no report about this patent.
Summary of the invention
The first purpose of this invention is that in view of the deficiencies of the prior art, providing one kind has effects that intelligence promoting and tranquilization helps sleep
Chinese medicine aromatotherapy composition.
Second object of the present invention is in view of the deficiencies of the prior art, to provide the purposes of composition as above.
Third object of the present invention is that in view of the deficiencies of the prior art, providing one kind has effects that intelligence promoting and tranquilization helps sleep
Chinese medicine aromatotherapy drug.
To realize above-mentioned first purpose, the technical solution adopted by the present invention is that:
A kind of Chinese medicine aromatotherapy composition for having effects that intelligence promoting and tranquilization and helping sleep, the composition is by such as the following weight
The bulk pharmaceutical chemicals of part are made: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, Flos Hibisci Mutabilis, camellia, west safflower, fingered citron
Flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower, cortex cinnamomi, Saussurea laniceps flower (are based on " middle traditional Chinese medicines
Allusion quotation ", " dictionary of medicinal plant ", " China book on Chinese herbal medicine " record, select nontoxic Saussurea laniceps flower, disable toxic snow lotus of big bud flower or new
Boundary saussurea involucrata or Herba Saussureae Involueratae), cloves, agalloch eaglewood, villous amomum flower.
As a preferred embodiment of the invention, being prepared into according to Chinese medicine conventional formulation preparation method can clinically be connect
The pharmaceutical preparation received.
As a preferred embodiment of the invention, the pharmaceutical preparation is aerosol, spray, paste, lotion, powder
Agent or oral solution.
To realize above-mentioned second purpose, the technical solution adopted by the present invention is that:
Composition as described above has effects that intelligence promoting and tranquilization helps answering in the Chinese medicine aromatotherapy drug slept in preparation
With.
A kind of Chinese medicine aromatotherapy drug for having effects that intelligence promoting and tranquilization and helping sleep, the composition of the drug from the above mentioned
It is made.
As a preferred embodiment of the invention, the drug the preparation method is as follows:
(1) dry above-mentioned raw materials medicine, each bulk pharmaceutical chemicals are crushed and are mixed after the parts by weight such as taking fresh or dehydration
It extracts to obtain plants essential oil by steam distillation or organic solvent extraction afterwards;
(2) plants essential oil for taking step (1) to obtain is dissolved as perfume ingredient, and to assign the ratio uniform that fragrant rate is 25%
In the ethanol solution that concentration is 95%, the parts by weight of the ethanol solution are 20 times of vegetable oil parts by weight;
(3) solution for obtaining step (2) filters, and obtains drug.
As a preferred embodiment of the invention, the organic solvent extraction is selected from one of the following:
A. take smashed bulk pharmaceutical chemicals, organic solvent be added to medicinal material is just submerged, then using water-bath reflow method into
Row extracts, and extracts 3 times altogether, extracts 1-3h every time, then extracting solution is recovered under reduced pressure after organic solvent under water-bath and obtains plant essence
Oil;
B. take smashed each raw material mixing, and organic solvent be added to medicinal material is just submerged, then using cold-maceration into
Row extracts, and extracts 3 times altogether, extracts 5-7d every time, then extracting solution is recovered under reduced pressure after organic solvent under water-bath and obtains plant essence
Oil.
Organic solvent as a preferred embodiment of the invention, in the organic solvent extraction are as follows: petroleum ether,
N-hexane, chloroform, ether or ethyl acetate.
As a preferred embodiment of the invention, the drug is treated by Chinese medicine aromatotherapy.
As a preferred embodiment of the invention, the Chinese medicine aromatotherapy is that fragrant inhalation therapy and fragrance are transdermal
Absorb therapy.
As a preferred embodiment of the invention, the usual way of the drug includes: fragrant pendant method, fragrant hat method, perfume (or spice)
Pillow method, fragrant pocket method, scent method, fragrant bath method, fragrant deposited method, perfume (or spice) press method.
As a preferred embodiment of the invention, the common formulations of the drug include: stacte, massage, brothers bath,
It baths, steam sucking, smearing, cold compress, hot compress, gargles, is sprayed, aerosol, showering agent, medicine-filled pillow agent.
For insomnia, the present invention uses syndrome differentiation of zang-fu viscera, and differentiation of eight principles, the differentiation of tri-jiao, it is former that the differentiation of channels and collaterals formulates treatment
Then, aromatics Chinese herbal medicine is selected with the property of Chinese materia medica theoretical (four gas, the five tastes, channel tropism, ascending-aescending-floating-sinking), formulates controlling for aromatotherapy
Treatment scheme --- Chinese medicine aromatotherapy.Because of the guiding theory fundamental difference followed, it is totally different from the treatment of west fragrance
Method.
For insomnia, current common Chinese medical discrimination, theoretical main threads is many, loses in touching briefly on the essentials, etiology and pathogenesis is caused to contain
Mixed, parting is many and diverse.And true human five internal organs' six internal organs are integral, and work hard in glove with connection conduction by channels and collaterals, internal organs actual situation is each other in table
Inside and outside sample relationship in-between.A certain card type is it is merely meant that in a certain internal organs, and pathological manifestations are a little prominent in a certain respect, and
Remaining internal organs remaining aspect is not represented there is no pathologic problems.If therefore from syndrome differentiation of zang-fu viscera, differentiation of eight principles, the differentiation of tri-jiao, warp
Network is dialectical to start with, and analyzes under morbid state, the three burnt pathological states that cold and heat and asthenia and sthenia in what kind of yin-yang table is in the five internal organs,
So etiology and pathogenesis of disease can often see the whole picture and very clear.
Below it is integrally recapitulative dialectical to the Chinese medicine of insomnia:
1, at the part of the body cavity above the diaphragm housing the heart and lungs (mark) --- deficiency of YIN-blood is disturbed in the fire of deficiency type.Lung: it is scorching on lung heat, based on lung-fire superinverse;The heart: in internal heat
Inflammation, based on mind disturbance, liver: liver-fire flaming, based on liver-yang hyperactivity, and perverse and unreasonable manner gram taste, it is weakness of the spleen and the stomach so that under liver and gallbladder damp-heat
Note.
2, in middle burnt (sheet) --- taste: weakness of the spleen and the stomach, deficiency-cold in spleen and stomach;Liver and gallbladder: stagnant heat in the liver and gall loses in catharsis;Taste are by wood
Fire multiplies, and phlegm wet extravasated blood is stagnated.
3, in lower burnt (sheet) --- kidney: yang-energy, which loses, is lost in storage, and the mistake of the nephrons cold of insufficiency type in taking the photograph admittedly;Liver kidney: liver-kidney deficiency, liver
Kidney deficiency;Water-wet and liver and gallbladder damp-heat bet.
Wherein part of the body cavity above the diaphragm housing the heart and lungs disease is often the mark of disease, and the sheet of its disease descends two cokes in really: lung-fire superinverse is mark, spleen
Stomach weakness is this;Flaring up of heart fire, mind disturbance is mark, water-fire imbalance, and the insufficiency of the kidney yang is this;Liver-fire flaming liver-yang hyperactivity is mark,
Kidney deficiency and liver, nephrons loss, water files to nourish wood for this;Phlegm wet extravasated blood is mark, and liver depression hyperactivity of fire is weakness of the spleen and the stomach, and wood fire gram soil, transporting is lost
Department is this;So based on the part of the body cavity above the diaphragm housing the heart and lungs temporary solution, based on lower two cokes effect a permanent cure in.
Fang Xie: be based on syndrome differentiation of zang-fu viscera, differentiation of eight principles, the differentiation of channels and collaterals, the differentiation of tri-jiao:
The part of the body cavity above the diaphragm housing the heart and lungs: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, Flos Hibisci Mutabilis, camellia, west safflower.
Middle coke: finger citron flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower.
Lower coke: cortex cinnamomi, Saussurea laniceps flower, cloves, agalloch eaglewood, villous amomum flower.
Our principle of reatment:
In the part of the body cavity above the diaphragm housing the heart and lungs, conscience lung --- -- clearing away the heart-fire, tranquilizing mind;Pancake irascibility, drop of diving liver-yang;Clearing lung-heat fire, respectful drop lung heat.With
Clearly, with drop, based on peace, based on temporary solution.
In middle coke, taste --- -- warm temperature supports taste, soothing liver-qi stagnation, activating microcirculation and removing stasis medicinal resolving sputum.With Wen Yangwenization, with transporting
Based on dredging, based on effecting a permanent cure.
In lower coke, liver kidney --- -- temperature compensation nephrons tonifies the liver and kidney, gas of receiving holds back mind;It fills up deficit and damages tonifying for the deficiency, guiding fire to origin;In temperature
On the basis of warming spleen and stomach, dispel damp and hot.Based on effecting a permanent cure.
The ingredient of armaticity Chinese medicine is mostly small-molecule substance, can quickly be absorbed by body, have priming uplink, resuscitation with aromatics more
Effect, Central nervous system have dual regulation, balance brain excitement and inhibit, so that the function of nervous centralis is tended to be flat
Weighing apparatus, sleeping of not only calming, but also consciousness regaining.Chinese medicine pharmacology points out that fragrant drug is inhaled by approach such as channels and collaterals, acupuncture point, skin, mucous membranes
Human body is taken in, plays the role of Yin Yang balancing, open and let out space between skin and muscles, declare smooth lung to defend, activating microcirculation and removing stasis medicinal.It can be seen that armaticity Chinese medicine has town
Quiet, syngignoscism can effectively treat insomnia, and adverse reaction is few.Modern pharmacological research proves that most of aromatics drugs can rise
To stimulation nervous centralis, accelerate nerve impulse conduction, the balance of cerebral cortex excitement and inhibition is adjusted, to such as intractable aypnia
Etc. illnesss improve significantly and therapeutic effect.Chinese medicine volatile materials is absorbed into body by skin, channels and collaterals, qi and blood etc., through gas
The circulation of blood passages through which vital energy circulates and throughout whole body, play relieve stagnation sleeping, nourishing functional activities of the body fluid blood, soothing the liver spleen, adjust nervous system excitement with
The effect of inhibition, to have the function that treatment of insomnia patients.
The invention has the advantages that:
1, natural aromatic advantage: the present invention is free of using pure natural aromatics flowers and aromatics plant as composition of prescription
There is any artificial synthetic ingredient.
2, advantage without side-effects: under the guidance of diagnosis and treatment based on an overall analysis of the illness and the patient's condition principle, selected each herbal medicine all passes through four natures and five flavors of drug,
Ascending-aescending-floating-sinking, channel tropism enter internal organs and modern pharmacology research, there was only excellent positive effect to human body, and without any side effects.
3, administration route advantage: fragrant inhalation and fragrant Transdermal absorption method are suitable for that overwhelming majority crowd uses, improve
The acceptance of patient.
4, diagnosis and treatment advantage: syndrome differentiation of zang-fu viscera, differentiation of eight principles, the differentiation of channels and collaterals, the differentiation of tri-jiao.
5, composition of prescription treating both manifestation and root cause of disease advantage: our tonifying spleen and stomach clearing lung-heat heat is with reinforcing earth to generate metal;Calming the liver is soothing the liver, the feeding taste of temperature,
To help soil suppression wood, activating microcirculation and removing stasis medicinal, regulating qi-flowing for eliminating phlegm;Kidney tonifying drops internal heat with restoring normal coordination between heart and kidney, and guiding fire to origin restrains floating sun, and gas of receiving is calmed the nerves;
Purpose is all treating both manifestation and root cause of disease.
6, composition of prescription is to be reduced to master, and based on heavy, to receive as main advantage: we are based on theoretical (four gas five of the property of Chinese materia medica
Taste, ascending-aescending-floating-sinking, channel tropism enter internal organs) and efficacy of drugs cure mainly as principle composition of prescription, for upward, dissipated to export-oriented table
Yang-energy to be reduced to master, based on heavy, based on receiving;In the part of the body cavity above the diaphragm housing the heart and lungs, internal heat, Pinggan Yang, respectful drop lung heat drop;Lower two burnt, the temperature in
Tonifying spleen and stomach, temperature compensation nephrons tonify the liver and kidney to restrain to take the photograph and receive, and guiding fire to origin, both help extreme misery.
Specific embodiment
The invention will be further elucidated with reference to specific embodiments.It should be understood that these embodiments are merely to illustrate this hair
It is bright rather than limit the scope of the invention.In addition, it should also be understood that, after having read the content of the invention recorded, art technology
Personnel can make various changes or modifications the present invention, and such equivalent forms equally fall within the application the appended claims and limited
Fixed range.
A kind of Chinese medicine aromatotherapy composition for having effects that intelligence promoting and tranquilization and helping sleep of embodiment 1
Bulk pharmaceutical chemicals are taken according to parts by weight equivalent proportion: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, lotus
Flower, camellia, west safflower, finger citron flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower, cortex cinnamomi,
Saussurea laniceps flower, cloves, agalloch eaglewood, villous amomum flower.
A kind of Chinese medicine aromatotherapy spray for having effects that intelligence promoting and tranquilization and helping sleep of embodiment 2
Bulk pharmaceutical chemicals are taken according to parts by weight equivalent proportion: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, lotus
Flower, camellia, west safflower, finger citron flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower, cortex cinnamomi,
Saussurea laniceps flower, cloves, agalloch eaglewood, villous amomum flower.Tool is prepared according to conventional pharmaceutical method in each bulk pharmaceutical chemicals and spray auxiliary material
There is intelligence development soothing nerves and assisting sleep to sleep the Chinese medicine aromatotherapy spray of effect.
A kind of Chinese medicine aromatotherapy paste for having effects that intelligence promoting and tranquilization and helping sleep of embodiment 3
Bulk pharmaceutical chemicals are taken according to parts by weight equivalent proportion: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, lotus
Flower, camellia, west safflower, finger citron flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower, cortex cinnamomi,
Saussurea laniceps flower, cloves, agalloch eaglewood, villous amomum flower.Each bulk pharmaceutical chemicals, which are prepared with paste auxiliary material according to conventional pharmaceutical method, to be had
Intelligence promoting and tranquilization helps the Chinese medicine aromatotherapy paste of sleep effect.
A kind of Chinese medicine aromatotherapy oral solution for having effects that intelligence promoting and tranquilization and helping sleep of embodiment 4
Bulk pharmaceutical chemicals are taken according to parts by weight equivalent proportion: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, lotus
Flower, camellia, west safflower, finger citron flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower, cortex cinnamomi,
Saussurea laniceps flower, cloves, agalloch eaglewood, villous amomum flower.Tool is prepared according to conventional pharmaceutical method in each bulk pharmaceutical chemicals and oral solution auxiliary material
There is intelligence development soothing nerves and assisting sleep to sleep the Chinese medicine aromatotherapy oral solution of effect.
5 zoopery of embodiment
1 experimental animal
Healthy ICR mouse, male, weight 18-22g, are randomly divided into 4 groups by weight by totally 32, and every group 8, weight between group
It examines through t without significant difference (p < 0.05).Wherein one group be blank group, excess-three group be respectively high dose group (200ml/kg),
Middle dose group (100ml/kg), low dose group (50ml/kg).
2 drugs
The oral solution that embodiment 4 is prepared.
3 experimental methods
Experiment carries out at night, carries out under 24 DEG C of -25 DEG C of quiet environments.
3.1 direct sleep experiments
Continuous gavage mouse 30d gives the given the test agent of 3 dosage, after control group gives 100ml/kg physiological saline, sees
Examine the sleep incidence of each group mouse, if sleep phenomenon, sleep occur using righting reflex loss as index.When mouse is placed in back
When clinostatism, can right immediately body position such as more than 30-60s cannot the person of righting, that is, righting reflex loss is thought, into sleep.It rights
Reflection restores to be animal awakening, and righting reflex loss is the animal sleep time to this period is restored, and records blank control group
With test sample group sleep number of animals and sleeping time.
3.2 extend the experiment of yellow Jackets sleeping time
First carry out preliminary experiment before doing formal experiment, determining makes animal 100% fall asleep, but do not make sleeping time it is too long penta
Barbital sodium dosage (30-60mg/kg.bw), is formally tested with this dosage.
After animal last gives blank control and various concentration given the test agent 10-15min, to groups of animals intraperitoneal injection penta
Barbital sodium, injection volume 0.2mL/20g, using righting reflex loss as index, can observation given the test agent extend amobarbital
Sodium sleeping time.
3.3 yellow Jackets sub-threshold dose hypnosis experiment
Preliminary experiment is first carried out before formal experiment, determines pentobarbital sodium sub-threshold lull dosage (16-30mg/kg.bw).Animal
After last gives blank control and various concentration given the test agent 10-15min, yellow Jackets maximum threshold is injected intraperitoneally in groups of animals
Lower hypnotic dose records sleep number of animals (righting reflex loss up to 1 minute or more person) in 30min.
The experiment of 3.4 barbital sodium Sleep latencies
Preliminary experiment is first carried out before doing formal experiment, determining makes animal 100% fall asleep, but does not make sleeping time too long bar
Than the dosage (200-300mg/kg) of appropriate sodium, formally tested with this dosage.
After animal last gives blank control and various concentration given the test agent 10-20min, groups of animals intraperitoneal injection bar is given
Than appropriate sodium, injection volume 0.2mL/20g observes given the test agent to barbital sodium sleep latency using righting reflex loss as index
The influence of phase.
4. carrying out one-way analysis of variance to experimental result with spss11.0 editions softwares, P < 0.05, P < 0.01 distinguish table
Show with significant difference and extremely significant difference.
5. experimental data and result judgement
5.1 direct sleep experiments
Continuous gavage mouse 30d gives the given the test agent of 3 dosage, and after control group gives same volume distilled water, last is given
After medicine, the activity condition of mouse in 60min is observed, without phenomenon of sleeping, mouse is living for sample sets and control group during this period
It is dynamic normal, illustrate we without the function of direct hypnosis.
5.2 extend the experiment of yellow Jackets sleeping time
First carry out preliminary experiment before doing formal experiment, determining makes animal 100% fall asleep, but do not make sleeping time it is too long penta
Barbital sodium dosage is 45mg/kg, is formally tested with this dosage.
After animal last gives blank control and various concentration given the test agent 10-15min, to groups of animals intraperitoneal injection penta
Barbital sodium, using righting reflex loss as index, can observation given the test agent extend yellow Jackets sleeping time.As a result see
The following table 1.
Table 1
Group | Dosage (ml/kg.bw) | Number of animals (only) | Sleeping time (min) | Rate elongation (%) |
High dose group | 200 | 8 | 77.36±8.25** | 207 |
Middle dose group | 100 | 8 | 75.26±12.36** | 200 |
Low dose group | 50 | 8 | 42.7±13.52* | 70 |
Blank group | 100 | 8 | 25.12±4.59 | 0 |
P < 0.01 * has highly significant difference compared to the blank group, and P < 0.05 * has significant difference compared to the blank group.
As can be seen from Table 1, the present composition compared to the blank group can significant Sleeping Time Prolong Ed (P <
0.01);Sleeping time after low dose group makes mouse give yellow Jackets extends 0.7 times, and middle dosage makes mouse give penta bar
Extend 2 times than the sleeping time after appropriate sodium, high dose and middle dose group are without significant difference.Show that the present composition compares penta bar
Appropriate sodium has synergistic effect.
5.3 yellow Jackets sub-threshold dose hypnosis experiment
By preliminary experiment, determine that pentobarbital sodium sub-threshold lull dosage is 25mg/kg.bw.Animal last gives blank group
And after various concentration given the test agent 10-15min, yellow Jackets maximum subthreshold hypnotic dosage, record is injected intraperitoneally in groups of animals
Sleep number of animals in 30min (righting reflex loss up to 1 minute or more person).It the results are shown in Table 2.
Table 2
Group | Dosage (ml/kg.bw) | Number of animals (only) | Sleep number (only) | Sleep rate (%) |
It is high | 200 | 8 | 6 | 75 |
In | 100 | 8 | 5 | 62.5 |
It is low | 50 | 8 | 4 | 50 |
Blank group | 100 | 8 | 2 | 25 |
The experiment of 5.4 barbital sodium Sleep latencies
By preliminary experiment, determining makes animal 100% fall asleep, but does not make the dosage of sleeping time too long barbital sodium
250mg/kg is formally tested with this dosage.After animal last gives blank control and various concentration given the test agent 10-20min, give
Barbital sodium is injected intraperitoneally in groups of animals, and injection volume 0.2mL/20g observes given the test agent using righting reflex loss as index
Influence to barbital sodium Sleep latency.It the results are shown in Table 3.
Table 3
Group | Dosage (ml/kg.bw) | Number of animals (only) | Sleep latency (min) |
It is high | 200 | 8 | 16.63±1.14** |
In | 100 | 8 | 17.02±3.34** |
It is low | 50 | 8 | 19.89±3.26* |
Blank group | 100 | 8 | 25.36±4.12 |
P < 0.01 * has highly significant difference compared to the blank group, and P < 0.05 * has significant difference compared to the blank group.
Above-mentioned table 3 statistics indicate that, the present composition can shorten compared to the blank group mice sleep incubation period (P <
0.01), low dose group makes mice sleep incubation period averagely shorten 5.47min, and middle dose group makes mice sleep incubation period averagely contract
Short 8.34min, high dose group make mice sleep incubation period averagely shorten 8.73min.High dose group and middle dose group are without conspicuousness
Difference.
In conclusion the present composition is able to extend yellow Jackets sleeping time, in yellow Jackets sub-threshold dose
With syngignoscism, barbital sodium Sleep latency can be shortened, the present composition is improving sleep function, treatment sleep disturbance
Aspect significant effect.
We are directed to insomnia, and with syndrome differentiation of zang-fu viscera, differentiation of eight principles, the differentiation of tri-jiao, the differentiation of channels and collaterals formulates principle of reatment,
Aromatics Chinese herbal medicine is selected with property of Chinese materia medica theory, formulates the therapeutic scheme of aromatotherapy --- Chinese medicine aromatotherapy.Compatibility group
Side is to be reduced to master, based on heavy, to receive as main advantage: based on the property of Chinese materia medica, theoretical (four natures and five flavors of drug, ascending-aescending-floating-sinking, channel tropism enter dirty
Internal organs) and efficacy of drugs cure mainly as principle composition of prescription, for upward, the yang-energy dissipated to export-oriented table is to sink to be reduced to master
It is main, based on receiving;In the part of the body cavity above the diaphragm housing the heart and lungs, internal heat, Pinggan Yang, respectful drop lung heat drop;Lower two burnt, warmly invigorating spleen and stomaches, temperature compensation nephrons, help liver in
Kidney is received with restraining to take the photograph, guiding fire to origin, and both help extreme misery.Using pure natural aromatics flowers and aromatics plant as composition of prescription, no
Contain any artificial synthetic ingredient.Using fragrant inhalation and fragrant Transdermal absorption method, it is suitable for that overwhelming majority crowd uses, improves
The acceptance of patient, curative effect are good, have very strong practicability.
The above is only a preferred embodiment of the present invention, it is noted that for the ordinary skill people of the art
Member, without departing from the principle of the present invention, can also make several improvement and supplement, these are improved and supplement also should be regarded as
Protection scope of the present invention.
Claims (9)
1. it is a kind of have effects that intelligence promoting and tranquilization help sleep Chinese medicine aromatotherapy composition, which is characterized in that the composition by
The bulk pharmaceutical chemicals of such as the following parts by weight are made: feverfew, wild chrysanthemum, wintercherry fruit or calyx, butterflybush flower, Chinese trumpet creeper, Flos Hibisci Mutabilis, camellia, west
Safflower, finger citron flower, rose, armeniaca mume, dalbergia wood, Flos Magnoliae Officinalis, inular flower, Flos Albiziae, broad bean flower, cortex cinnamomi, Saussurea laniceps flower, fourth
Perfume, agalloch eaglewood, villous amomum flower.
2. composition according to claim 1, which is characterized in that be prepared into clinic according to Chinese medicine conventional formulation preparation method
Upper acceptable pharmaceutical preparation.
3. composition according to claim 2, which is characterized in that the pharmaceutical preparation be aerosol, spray, paste,
Lotion, pulvis or oral solution.
4. composition described in claim 1 has effects that intelligence promoting and tranquilization helps in the Chinese medicine aromatotherapy drug of sleep in preparation
Using.
5. a kind of Chinese medicine aromatotherapy drug for having effects that intelligence promoting and tranquilization and helping sleep, which is characterized in that the drug is by right
It is required that composition described in 1 is made.
6. drug according to claim 5, which is characterized in that the drug the preparation method is as follows:
Dry bulk pharmaceutical chemicals, each bulk pharmaceutical chemicals are crushed and are mixed after the parts by weight such as taking described in claim 1 fresh or dehydration
It extracts to obtain the drug by steam distillation or organic solvent extraction after conjunction.
7. drug according to claim 5, which is characterized in that the drug the preparation method is as follows:
(1) dry bulk pharmaceutical chemicals, each bulk pharmaceutical chemicals are crushed simultaneously after the parts by weight such as taking described in claim 1 fresh or dehydration
It extracts to obtain plants essential oil by steam distillation or organic solvent extraction after mixing;
(2) plants essential oil for taking step (1) to obtain is dissolved as perfume ingredient, and to assign fragrant rate as the ratio uniform of 15-25%
In the ethanol solution that concentration is 95%, the parts by weight of the ethanol solution are 20 times of vegetable oil parts by weight;
(3) solution for obtaining step (2) filters, and obtains drug.
8. drug according to claim 6, which is characterized in that the organic solvent extraction is selected from one of the following:
A. smashed bulk pharmaceutical chemicals are taken, organic solvent is added to medicinal material is just submerged, is then mentioned using water-bath reflow method
It takes, extracts 3 times altogether, extract 1-3h every time, then obtain plants essential oil after organic solvent is recovered under reduced pressure under water-bath in extracting solution;
B. smashed each raw material mixing is taken, and organic solvent is added to medicinal material is just submerged, is then mentioned using cold-maceration
It takes, extracts 3 times altogether, extract 5-7d every time, then obtain plants essential oil after organic solvent is recovered under reduced pressure under water-bath in extracting solution.
9. drug according to claim 6, which is characterized in that the organic solvent in the organic solvent extraction are as follows: stone
Oily ether, n-hexane, chloroform, ether or ethyl acetate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910446153.1A CN110123981A (en) | 2019-05-27 | 2019-05-27 | A kind of Chinese medicine aromatotherapy composition and its application for having effects that intelligence promoting and tranquilization and helping sleep |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910446153.1A CN110123981A (en) | 2019-05-27 | 2019-05-27 | A kind of Chinese medicine aromatotherapy composition and its application for having effects that intelligence promoting and tranquilization and helping sleep |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110123981A true CN110123981A (en) | 2019-08-16 |
Family
ID=67581857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910446153.1A Pending CN110123981A (en) | 2019-05-27 | 2019-05-27 | A kind of Chinese medicine aromatotherapy composition and its application for having effects that intelligence promoting and tranquilization and helping sleep |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110123981A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113288834A (en) * | 2021-04-23 | 2021-08-24 | 花安堂生物科技集团有限公司 | New application of Magnolia sieboldii extract |
CN113730511A (en) * | 2021-09-17 | 2021-12-03 | 吉首大学 | Eucommia male flower formula composition capable of soothing nerves and helping sleep and application of eucommia male flower formula composition |
CN114632036A (en) * | 2020-12-16 | 2022-06-17 | 蔻诗曼嘉韩国股份公司 | Pressure-relieving and mind-stabilizing extract water composition containing rose extract and camellia extract |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109793870A (en) * | 2019-04-04 | 2019-05-24 | 上海市同济医院 | A kind of pure plant essence perfume with antidepression antianxiety |
-
2019
- 2019-05-27 CN CN201910446153.1A patent/CN110123981A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109793870A (en) * | 2019-04-04 | 2019-05-24 | 上海市同济医院 | A kind of pure plant essence perfume with antidepression antianxiety |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114632036A (en) * | 2020-12-16 | 2022-06-17 | 蔻诗曼嘉韩国股份公司 | Pressure-relieving and mind-stabilizing extract water composition containing rose extract and camellia extract |
KR20240076766A (en) * | 2020-12-16 | 2024-05-30 | 주식회사 코스메카코리아 | Aromatic composition containing extract of rosa hybrid and extract of camellia japonica flower for psychological relaxation |
KR102678013B1 (en) | 2020-12-16 | 2024-06-26 | 주식회사 코스메카코리아 | Aromatic composition containing extract of rosa hybrid and extract of camellia japonica flower for psychological relaxation |
CN113288834A (en) * | 2021-04-23 | 2021-08-24 | 花安堂生物科技集团有限公司 | New application of Magnolia sieboldii extract |
CN113730511A (en) * | 2021-09-17 | 2021-12-03 | 吉首大学 | Eucommia male flower formula composition capable of soothing nerves and helping sleep and application of eucommia male flower formula composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432475B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
CN110123981A (en) | A kind of Chinese medicine aromatotherapy composition and its application for having effects that intelligence promoting and tranquilization and helping sleep | |
CN103099866B (en) | Traditional Chinese medicine composition for treating anxiety and insomnia and preparation method thereof | |
CN102772704B (en) | Medicament for treating geriatric disease | |
CN101797317A (en) | Chinese medicinal composition for relieving mind and calming nerve | |
CN109793870A (en) | A kind of pure plant essence perfume with antidepression antianxiety | |
CN107412589A (en) | A kind of multifunction sleeping-aid mind-tranquilizing brain-strengthening pack | |
CN104127813A (en) | Traditional Chinese medicinal composition for curing qi-blood deficiency type bedsore and preparation method thereof | |
CN102198253A (en) | Traditional Chinese medicine composition for resisting depression, and preparation method as well as application thereof | |
CN103784768A (en) | Traditional Chinese medicine composition for treating palpitation | |
CN106074959A (en) | Black-eyed Chinese medicine composition of a kind of alleviation and preparation method thereof | |
CN105535127A (en) | Foot bath powder containing folium artemisiae argyi dregs and achieving sleep improvement function and preparation method thereof | |
CN103316250B (en) | Traditional Chinese medicine composition for treating cardiopalmus | |
CN106902257A (en) | A kind of Chinese medicine composition of facial paralysis and preparation method thereof | |
CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
CN105920379A (en) | Traditional Chinese medicine eye cream to alleviate pouch and preparation method thereof | |
CN109200191A (en) | Restrain myogenic, Chinese materia medica preparation of light speckles, beautification and white and preparation method thereof | |
CN103961578A (en) | Traditional Chinese medicine medicinal liquor for treating neurasthenia | |
CN116350704B (en) | Traditional Chinese medicine composition for treating secondary epilepsy and preparation method thereof | |
CN103736027A (en) | Traditional Chinese medicine composition for treating insomnia | |
CN107875297A (en) | A kind of Chinese medicine composition for treating vertigo and preparation method thereof | |
CN113521145B (en) | Traditional Chinese medicine composition for soothing nerves and helping sleep as well as preparation method and application thereof | |
CN105943485A (en) | Method for preparing traditional Chinese medicine eye cream for relieving pouch and eye cream prepared by same | |
CN104958236A (en) | Traditional Chinese medicine eye cream capable of relieving eye pouches and eye swelling and preparation method of eye cream | |
CN104524092A (en) | Traditional Chinese medicine composition for treating nervous tinnitus and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190816 |